CG Oncology (NASDAQ:CGON) Given Buy Rating at HC Wainwright
HC Wainwright restated their buy rating on shares of CG Oncology (NASDAQ:CGON – Free Report) in a research note released on Monday morning,Benzinga reports. HC Wainwright currently has a $75.00 price objective on the stock. Several other research analysts have also recently issued reports on the stock. Scotiabank began coverage on shares of CG Oncology […]
HC Wainwright restated their buy rating on shares of CG Oncology (NASDAQ:CGON – Free Report) in a research note released on Monday morning,Benzinga reports. HC Wainwright currently has a $75.00 price objective on the stock. Several other research analysts have also recently issued reports on the stock. Scotiabank began coverage on shares of CG Oncology […]
